Episode

GLP-1s and Cancer Part 2 - Early Research

Podcast
Weight and Healthcare
Published
Jun 17, 2026
Duration seconds
1060
Processing state
not_requested
Canonical source
https://weightandhealthcare.substack.com/p/glp-1s-and-cancer-part-2-early-research
Audio
https://api.substack.com/feed/podcast/202214343/ce1d1fca47b98275f48358f8a919ac57.mp3
JSON
/v1/public/podcasts/weight-and-healthcare-6448206/episodes/glp-1s-and-cancer-part-2-early-research
Markdown
/podcast/weight-and-healthcare-6448206/glp-1s-and-cancer-part-2-early-research.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/weight-and-healthcare-6448206/episodes/glp-1s-and-cancer-part-2-early-research/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/weight-and-healthcare-6448206/glp-1s-and-cancer-part-2-early-research.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In part 1 I discussed the basics of the deluge of studies coming out looking at GLP-1s and cancer. If you haven’t read part 1 yet, I would recommend doing so as I’ll be referring to it a lot as I move through the rest of this series. Today we’re going to look at a study that considers relatively earlier data around GLP-1s and breast cancer. Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe